Molecular Epidemiology and Pathogenicity of C. auris in Guangzhou

Study Background and Research Question

Candidozyma auris (formerly Candida auris) has rapidly emerged as a global multidrug-resistant fungal pathogen, responsible for healthcare-associated infections with high mortality and limited therapeutic options. Since its first identification in Japan in 2009, C. auris has been reported in over 50 countries and is now recognized by the World Health Organization as a critical public health threat due to its ability to cause outbreaks and its notable antifungal resistance. In China, the incidence of C. auris has increased sharply in recent years, culminating in a substantial surge in 2023, but detailed molecular epidemiological data from South China have been limited. The research question addressed by Wan et al. (BMC Microbiology, 2026) centers on the genetic diversity, antifungal resistance mechanisms, and pathogenicity profiles of C. auris isolates circulating in Guangzhou hospitals.

Key Innovation from the Reference Study

The reference study delivers the first comprehensive molecular and phenotypic characterization of C. auris in Guangzhou, revealing the presence of two major genetic clades (Clade I and Clade III) and systematically linking clade identity to antifungal susceptibility, resistance mutations, and virulence factors. Notably, the study integrates whole genome sequencing (WGS), detailed antifungal susceptibility testing, extracellular hydrolase activity quantification, biofilm formation assays, and in vivo pathogenicity models, enabling multi-dimensional insights into local epidemiological patterns and resistance evolution. The investigation bridges genetic findings with clinically relevant phenotypes, enhancing the scientific foundation for targeted infection control and stewardship approaches in the region.

Methods and Experimental Design Insights

Wan et al. employed a multi-platform approach to dissect the epidemiology and biology of C. auris in a clinical context. Thirty-nine isolates from 37 patients across three Guangzhou hospitals were collected and analyzed. The study’s major methodological steps included:

• Whole Genome Sequencing (WGS): High-resolution SNP analysis and phylogenetic reconstruction were performed to assign clade identity and infer genetic relationships.
• Antifungal Susceptibility Testing: Standardized protocols assessed susceptibility to fluconazole, echinocandins, and amphotericin B, and resistance mutations were mapped using genome data.
• Hydrolase and Biofilm Assays: Secreted aspartyl protease (SAP) activity and biofilm-forming potential were quantified using established cell and plate-based assays. Nuclear staining dyes such as crystal violet are often integral to these protocols for visualizing and quantifying biofilm biomass, as discussed in assay optimization articles (e.g., Crystal Violet Staining Solution: Reliable Nuclear Staining in Cell Assays).
• In Vivo Pathogenicity Model: Virulence was evaluated in Galleria mellonella larvae, providing a functional readout of infection severity and host mortality across clades.

This combined design allowed direct linking of genotype, drug resistance, and virulence characteristics.

Core Findings and Why They Matter

The study’s findings establish two dominant C. auris clades in Guangzhou: Clade I (74.4% of isolates) and Clade III (25.6%), with rare co-infection events observed. All isolates exhibited resistance to fluconazole, a frontline antifungal, while remaining sensitive to echinocandins; most Clade I isolates also showed resistance to amphotericin B. Genetically, all strains harbored ERG11 mutations (K143R or F126L), which are known mediators of fluconazole resistance, but no mutations in genes linked to echinocandin or amphotericin B resistance were detected.

Functional assays revealed clade-specific virulence traits: Clade I displayed potent secreted aspartyl protease activity, correlating with higher pathogenicity and mortality in the Galleria mellonella model, whereas Clade III demonstrated enhanced biofilm-forming capacity, which may facilitate persistence in clinical and environmental settings. The ability to form robust biofilms is especially concerning in healthcare environments, as biofilm-associated cells often display increased resistance to both antifungals and disinfection protocols—a phenomenon well-documented in related assay research (LL-37 and Mimetics: Selective Antibiofilm Action via Crystal Violet Assays).

These findings underscore the importance of local molecular surveillance and the need for tailored infection control strategies, given the clade-dependent variation in resistance and virulence. The data also contribute to the expanding global genetic database of C. auris, supporting comparative epidemiological analyses.

Comparison with Existing Internal Articles

The reference study’s integration of molecular genetics, resistance profiling, and virulence assays aligns with, and extends, prior research in the region. For example, an earlier local study (Genomic and Phenotypic Characterization of C. auris in South China) similarly highlighted distinct clade distributions and resistance patterns, but the current work advances the field by linking these patterns to secreted enzyme activity and in vivo pathogenicity.

Additionally, the use of nuclear staining dyes such as Crystal Violet Staining Solution in biofilm and cell-based assays is echoed in methodological articles (Crystal Violet Staining Solution: Reliable Nuclear Staining in Cell Assays; Decoding Biofilm and Nucleus Interactions), emphasizing the importance of standardized, high-contrast staining for reproducible quantification of biofilm mass and nuclear integrity in fungal studies. This methodological consistency supports robust phenotype-genotype correlations, as demonstrated in the reference paper.

Limitations and Transferability

While the study provides a comprehensive snapshot of C. auris epidemiology in Guangzhou, some limitations affect wider generalizability. The sample, though representative of three major hospitals, may not capture all circulating lineages or reflect temporal shifts in clade prevalence or resistance patterns. The use of the Galleria mellonella model, while widely accepted, may not fully recapitulate human infection dynamics. Additionally, environmental and interventional variables specific to Guangzhou healthcare settings may limit direct extension to other regions.

Nevertheless, the combined genomic and phenotypic approach offers a valuable template for surveillance and control in other high-risk settings, especially where multidrug-resistant C. auris poses an emerging or ongoing threat.

Protocol Parameters

• Isolate collection and storage: Clinical isolates should be collected using sterile swabs or aspirates and stored at −80°C until processing.
• Whole genome sequencing: Extract genomic DNA using a validated fungal DNA extraction kit; sequencing libraries prepared for Illumina or equivalent platforms.
• Antifungal susceptibility testing: Perform microdilution assays following CLSI or EUCAST guidelines; interpret minimum inhibitory concentrations (MICs) according to latest standards.
• Biofilm quantification using nuclear staining dye: After incubation, stain biofilms with a 2% crystal violet solution for 15–30 minutes, wash thoroughly, then solubilize the dye in ethanol or acetic acid before measuring absorbance at 570–600 nm (see internal protocol discussion).
• Galleria mellonella infection: Inject larvae with standardized fungal cell suspensions; monitor survival for up to 7 days at 30–37°C.

Research Support Resources

For laboratories aiming to reproduce or extend these findings, high-quality nuclear staining dyes are essential for reliable biofilm and cell population assays. Researchers can utilize Crystal Violet Staining Solution (SKU K1184), a 2% alkaline dye extensively used for colony formation, cell migration, and cell invasion assays, as well as for quantifying biofilm mass in fungal and bacterial studies. This reagent is supplied by APExBIO and is designed for robust, reproducible nuclear staining, facilitating precise microscopic and colorimetric analysis in both basic and translational mycology workflows.